DelRicht Research is proud to highlight the outstanding performance of our investigators and site teams in a Phase 4 clinical trial focused on attention-deficit/hyperactivity disorder (ADHD) in children ages 4-12. Over the course of a 14-month enrollment period, our network significantly exceeded our expected target, highlighting DelRicht’s adaptability and precision in pediatric psychiatry research.

This trial required a thoughtful approach to scheduling, strong clinical expertise in pediatric care, and the ability to build trust with both children and their families. Through these combined efforts, DelRicht delivered results that directly impacted the trial’s success.

Surpassing Enrollment Expectations

The sponsor’s national goal for this Phase 4 study was to recruit 230 participants across 20 sites. DelRicht’s New Orleans site, led by Dr. Caroline Campion at Touro Medical Center, was expected to enroll 12 participants. By the end of the enrollment period, the site had enrolled 21 participants, 183% of the assigned goal, positioning itself among the trial’s top-performing locations.

Reaching nearly double the expected enrollment demonstrated our ability to engage families in a highly competitive pediatric research environment. The accomplishment also underscored DelRicht’s capacity to contribute meaningfully to multi-site studies where each additional participant plays a critical role in powering the study to completion.

Meeting Trial Challenges with Care and Adaptability

This study introduced two major challenges that required careful planning and execution:

Balancing study visits with school obligations
The protocol required weekly study visits during the school year, creating scheduling conflicts for families. For children and their parents, missing classroom time could pose a barrier to participation.

Supporting children through frequent blood draws
Weekly pediatric blood collections were necessary for the study but created stress for both children and caregivers. Ensuring both technical accuracy and emotional comfort was essential to retention.

DelRicht overcame these barriers through a two-pronged approach:

First, our coordinators provided early-morning and late-afternoon appointments, giving parents the flexibility to schedule visits before or after school hours. This minimized disruption to daily routines and helped sustain long-term engagement.

Second, our clinical teams emphasized a compassionate and reassuring approach to weekly blood draws. By pairing technical expertise with sensitivity to each child’s needs, our staff created an environment that reduced anxiety and built trust over time. Families felt supported, and children remained more at ease with ongoing participation.

These measures ensured that compliance remained strong across the enrollment period while simultaneously supporting data integrity and patient well-being.

Community Trust, Sponsor Confidence

The success of this trial was rooted in Dr. Caroline Campion’s leadership and her established relationship with the New Orleans community. Parents felt confident bringing their children into a trusted environment where they would be treated with respect, care, and professionalism.

This strong physician-patient trust, combined with DelRicht’s structured operational support, allowed our team to exceed expectations and deliver reliable results. For sponsors and CROs, this performance demonstrated DelRicht’s ability to meet enrollment needs and commitment to ensuring high-quality participation in pediatric psychiatry studies.

What This Means for Sponsors and CROs

This case study highlights several differentiators that sponsors and CROs can expect when partnering with DelRicht in pediatric psychiatry and beyond:

– Flexible scheduling strategies that prioritize school-aged participants while accommodating family routines.
– Compassionate pediatric expertise that reduces anxiety in high-frequency study protocols, strengthening retention.
– Proven enrollment performance that consistently exceeds expectations, ensuring studies are powered efficiently.

These results reflect DelRicht’s broader ability to operationalize complex protocols in community-based settings where trust, accessibility, and care drive outcomes.

Partner With Us

At DelRicht Research, we believe successful clinical trials require supporting participants and families at every stage of the process. Whether in pediatric psychiatry or across our nine therapeutic areas, our embedded site model combines operational excellence with local community trust to deliver results that matter.

If you’re seeking a partner who can consistently transform recruitment challenges into sponsor success stories, we’d love to connect.

Learn more about our work at www.DelRichtResearch.com or reach out to explore collaboration opportunities.